There is also prior work demonstrating that patients with increased PGRMC1 have decreased overall survival (HR = 1.7; P = 0.029; ref. 83), but the latter publication did not account for the association of PGRMC1 with proliferation, which is known to correlate with worse survival outcomes in patients with breast cancer. Here, PGRMC1 is linked to breast carcinoma.